Debt-to-equity of Co-Diagnostics, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Co-Diagnostics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 15%, a 29% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 15% +3.3% +29% 30 Sep 2025
Q2 2025 15% +4.4% +43% 30 Jun 2025
Q1 2025 14% +4.3% +44% 31 Mar 2025
Q4 2024 13% +4.4% +52% 31 Dec 2024
Q3 2024 11% +3.7% +47% 30 Sep 2024
Q2 2024 10% +2.4% +30% 30 Jun 2024
Q1 2024 9.8% +1.1% +12% 31 Mar 2024
Q4 2023 8.6% -2.7% -24% 31 Dec 2023
Q3 2023 7.8% -6.1% -44% 30 Sep 2023
Q2 2023 8% -5.4% -40% 30 Jun 2023
Q1 2023 8.8% -4% -31% 31 Mar 2023
Q4 2022 11% +0.98% +9.5% 31 Dec 2022
Q3 2022 14% +7.8% +129% 30 Sep 2022
Q2 2022 13% +7.5% +126% 30 Jun 2022
Q1 2022 13% +6.5% +105% 31 Mar 2022
Q4 2021 10% +4.1% +67% 31 Dec 2021
Q3 2021 6.1% -0.06% -0.98% 30 Sep 2021
Q2 2021 5.9% -3% -33% 30 Jun 2021
Q1 2021 6.2% -3.4% -35% 31 Mar 2021
Q4 2020 6.2% -6.9% -53% 31 Dec 2020
Q3 2020 6.2% -27% -81% 30 Sep 2020
Q2 2020 8.9% -58% -87% 30 Jun 2020
Q1 2020 9.6% -101% -91% 31 Mar 2020
Q4 2019 13% -219% -94% 31 Dec 2019
Q3 2019 33% -30% -48% 30 Sep 2019
Q2 2019 66% +42% +170% 30 Jun 2019
Q1 2019 110% +9.1% +9% 31 Mar 2019
Q4 2018 232% 31 Dec 2018
Q3 2018 63% 30 Sep 2018
Q2 2018 25% 30 Jun 2018
Q1 2018 101% 31 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.